Thermo Fisher Scientific (TMO)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
Key Insights
Critical company metrics and information
Share Price
$529.36Market Cap
$202.48 BillionTotal Outstanding Shares
382.50 Million SharesTotal Employees
122,000Dividend
$0.39 Per Share QuarterlyIPO Date
August 27, 1980SIC Description
Measuring & Controlling Devices, NecHomepage
https://www.thermofisher.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
September 29, 2023 to September 28, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $-1.69 Billion |
Net Cash Flow From Operating Activities, Continuing | $9.10 Billion |
Net Cash Flow From Operating Activities | $9.10 Billion |
Net Cash Flow From Financing Activities | $-4.55 Billion |
Net Cash Flow From Financing Activities, Continuing | $-4.55 Billion |
Net Cash Flow From Investing Activities | $-6.24 Billion |
Net Cash Flow | $-1.69 Billion |
Net Cash Flow From Investing Activities, Continuing | $-6.24 Billion |
Income Statement
September 29, 2023 to September 28, 2024
Metric | Value |
---|---|
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Net Income/Loss | $6.12 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Net Income/Loss Available To Common Stockholders, Basic | $6.13 Billion |
Income/Loss From Continuing Operations After Tax | $6.20 Billion |
Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $17.00 Million |
Income Tax Expense/Benefit | $640.00 Million |
Basic Earnings Per Share | $16.00 |
Other Operating Expenses | $25.33 Billion |
Revenues | $42.37 Billion |
Income/Loss Before Equity Method Investments | $6.84 Billion |
Selling, General, and Administrative Expenses | $8.52 Billion |
Income/Loss From Continuing Operations Before Tax | $6.84 Billion |
Research and Development | $1.34 Billion |
Diluted Earnings Per Share | $15.95 |
Basic Average Shares | $382.00 Million |
Income/Loss From Equity Method Investments | $-76.00 Million |
Costs And Expenses | $35.20 Billion |
Benefits Costs and Expenses | $35.53 Billion |
Operating Expenses | $35.20 Billion |
Diluted Average Shares | $383.00 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $-15.00 Million |
Operating Income/Loss | $7.17 Billion |
Net Income/Loss Attributable To Parent | $6.13 Billion |
Balance Sheet
September 29, 2023 to September 28, 2024
Metric | Value |
---|---|
Other Non-current Assets | $50.91 Billion |
Temporary Equity | $127.00 Million |
Noncurrent Assets | $76.58 Billion |
Other Current Assets | $18.35 Billion |
Other Current Liabilities | $10.17 Billion |
Long-term Debt | $35.11 Billion |
Equity Attributable To Noncontrolling Interest | $-20.00 Million |
Current Assets | $23.78 Billion |
Equity Attributable To Parent | $48.99 Billion |
Accounts Payable | $2.61 Billion |
Liabilities | $51.39 Billion |
Current Liabilities | $14.60 Billion |
Wages | $1.82 Billion |
Equity | $48.97 Billion |
Noncurrent Liabilities | $36.79 Billion |
Other Non-current Liabilities | $1.68 Billion |
Assets | $100.36 Billion |
Liabilities And Equity | $100.36 Billion |
Inventory | $5.43 Billion |
Intangible Assets | $16.26 Billion |
Redeemable Noncontrolling Interest | $127.00 Million |
Fixed Assets | $9.41 Billion |
Historical Dividends
Current dividend: $0.39 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Nov 7, 2024 | Jan 15, 2025 | Dec 13, 2024 | $0.39 | Quarterly |
Jul 11, 2024 | Oct 15, 2024 | Sep 13, 2024 | $0.39 | Quarterly |
May 22, 2024 | Jul 15, 2024 | Jun 14, 2024 | $0.39 | Quarterly |
Feb 21, 2024 | Apr 15, 2024 | Mar 15, 2024 | $0.39 | Quarterly |
Nov 9, 2023 | Jan 16, 2024 | Dec 15, 2023 | $0.35 | Quarterly |
Jul 13, 2023 | Oct 13, 2023 | Sep 15, 2023 | $0.35 | Quarterly |
May 24, 2023 | Jul 14, 2023 | Jun 15, 2023 | $0.35 | Quarterly |
Feb 22, 2023 | Apr 14, 2023 | Mar 15, 2023 | $0.35 | Quarterly |
Nov 10, 2022 | Jan 16, 2023 | Dec 15, 2022 | $0.3 | Quarterly |
Jul 7, 2022 | Oct 14, 2022 | Sep 15, 2022 | $0.3 | Quarterly |
May 18, 2022 | Jul 15, 2022 | Jun 15, 2022 | $0.3 | Quarterly |
Feb 23, 2022 | Apr 14, 2022 | Mar 16, 2022 | $0.3 | Quarterly |
Nov 4, 2021 | Jan 14, 2022 | Dec 15, 2021 | $0.26 | Quarterly |
Jul 8, 2021 | Oct 15, 2021 | Sep 15, 2021 | $0.26 | Quarterly |
May 19, 2021 | Jul 15, 2021 | Jun 15, 2021 | $0.26 | Quarterly |
Feb 23, 2021 | Apr 16, 2021 | Mar 16, 2021 | $0.26 | Quarterly |
Nov 5, 2020 | Jan 15, 2021 | Dec 15, 2020 | $0.22 | Quarterly |
Jul 9, 2020 | Oct 15, 2020 | Sep 15, 2020 | $0.22 | Quarterly |
May 20, 2020 | Jul 15, 2020 | Jun 15, 2020 | $0.22 | Quarterly |
Feb 25, 2020 | Apr 16, 2020 | Mar 16, 2020 | $0.22 | Quarterly |
Nov 8, 2019 | Jan 15, 2020 | Dec 17, 2019 | $0.19 | Quarterly |
Jul 11, 2019 | Oct 15, 2019 | Sep 17, 2019 | $0.19 | Quarterly |
May 23, 2019 | Jul 16, 2019 | Jun 14, 2019 | $0.19 | Quarterly |
Feb 26, 2019 | Apr 16, 2019 | Mar 15, 2019 | $0.19 | Quarterly |
Nov 8, 2018 | Jan 15, 2019 | Dec 17, 2018 | $0.17 | Quarterly |
Jul 13, 2018 | Oct 15, 2018 | Sep 17, 2018 | $0.17 | Quarterly |
May 24, 2018 | Jul 16, 2018 | Jun 15, 2018 | $0.17 | Quarterly |
Jan 31, 2018 | Apr 16, 2018 | Mar 15, 2018 | $0.17 | Quarterly |
Nov 9, 2017 | Jan 15, 2018 | Dec 15, 2017 | $0.15 | Quarterly |
Jul 12, 2017 | Oct 16, 2017 | Sep 15, 2017 | $0.15 | Quarterly |
May 18, 2017 | Jul 17, 2017 | Jun 15, 2017 | $0.15 | Quarterly |
Feb 28, 2017 | Apr 17, 2017 | Mar 15, 2017 | $0.15 | Quarterly |
Jul 7, 2016 | Oct 17, 2016 | Sep 15, 2016 | $0.15 | Quarterly |
May 18, 2016 | Jul 15, 2016 | Jun 15, 2016 | $0.15 | Quarterly |
Feb 25, 2016 | Apr 15, 2016 | Mar 15, 2016 | $0.15 | Quarterly |
Nov 12, 2015 | Jan 15, 2016 | Dec 15, 2015 | $0.15 | Quarterly |
Jul 10, 2015 | Oct 15, 2015 | Sep 15, 2015 | $0.15 | Quarterly |
May 21, 2015 | Jul 15, 2015 | Jun 15, 2015 | $0.15 | Quarterly |
Feb 25, 2015 | Apr 15, 2015 | Mar 16, 2015 | $0.15 | Quarterly |
Nov 6, 2014 | Jan 15, 2015 | Dec 15, 2014 | $0.15 | Quarterly |
Jul 10, 2014 | Oct 15, 2014 | Sep 15, 2014 | $0.15 | Quarterly |
May 20, 2014 | Jul 15, 2014 | Jun 16, 2014 | $0.15 | Quarterly |
Feb 26, 2014 | Apr 15, 2014 | Mar 17, 2014 | $0.15 | Quarterly |
Nov 7, 2013 | Jan 15, 2014 | Dec 16, 2013 | $0.15 | Quarterly |
Jul 11, 2013 | Oct 15, 2013 | Sep 16, 2013 | $0.15 | Quarterly |
May 22, 2013 | Jul 15, 2013 | Jun 17, 2013 | $0.15 | Quarterly |
Feb 26, 2013 | Apr 15, 2013 | Mar 15, 2013 | $0.15 | Quarterly |
Nov 8, 2012 | Jan 15, 2013 | Dec 17, 2012 | $0.15 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Thermo Fisher Scientific (TMO)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.